Comparison of Intravitreal Bevacizumab and Intravitreal Diclofenac in the Treatment of Diabetic Macular Edema: a 6-month Follow-up

The aim of this study was to compare the effect of intravitreal diclofenac, a non-steroidal anti-inflammatory drug (NSAID), with that of bevacizumab, a well-known anti-vascular endothelial growth factor (VEGF) drug, in the treatment of diabetic macular edema (DME). Diclofenac was chosen in this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: FAGHIHI, Hooshang, YAHYAPOUR, Hanif, MAHMOUDZADEH, Raziyeh, FAGHIHI, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787025/
https://www.ncbi.nlm.nih.gov/pubmed/29392145

Ejemplares similares

Ejemplares similares